Skip to main content
SpringerLink
Log in

HRQOL and economic analyses of SYNTAX reported

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Cohen DJ, Lavelle TA, Serruys PW, Mohr FW, Li H, Lei Y, Wang K, Robertus K, Mahoney EM, Zhu Y, Dawkins KD, Kappetein AP, SYNTAX Investigators.Health related quality of life and U.S. economic outcomes of PCl with drug-eluting stents vs. bypass surgery: 1-year results from the SYNTAX Trial. 58th Annual Scientific Session of the American College of Cardiology (Late Breaking Abstr.): [11 pages] (plus oral presentation), 29 Mar 2009. Available from: URL: http://www.sciencedirect.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HRQOL and economic analyses of SYNTAX reported. Pharmacoecon. Outcomes News 576, 6 (2009). https://doi.org/10.2165/00151234-200905760-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905760-00016

Keywords

Search

Navigation